🩺

Gastroenterology

67 drugs in pipeline from 10 companies

Drugs in Pipeline

Companies

Upcoming Catalysts

Phase 3 Trials

Upcoming Catalysts

Feb 1

INCYPhase 2Phase 2

Asparaginase Erwinia Chrysanthemi Phase 2 Results Expected

Asparaginase Erwinia Chrysanthemi • Leukemia

Mar 2026~

AVTXPhase 2Phase 2

AVTX-009 Regimen 1 Phase 2 Results Expected

AVTX-009 Regimen 1 • Hidradenitis Suppurativa

Mar 2026~

AARD⭐Phase 3Phase 3

Placebo Phase 3 Results Expected

Placebo • Hyperphagia

Mar 31

4523.TPhase 2Phase 2

E7090 Phase 2 Results Expected

E7090 • Cholangiocarcinoma

Apr 18

LSTAPhase 2Phase 2

certepetide Phase 2 Results Expected

certepetide • Cholangiocarcinoma

View all catalysts

Pipeline by Phase

Phase 3

Phase 2

Active Companies

OCUL

OCULAR THERAPEUTIX, INC

3 drugs

ALDX

Aldeyra Therapeutics, Inc.

3 drugs

IRWD

IRONWOOD PHARMACEUTICALS INC

Sanofi

Phathom Pharmaceuticals, Inc.

Astellas Pharma Inc.

Kyowa Kirin Co., Ltd.

1 drugs

COGT

Cogent Biosciences, Inc.

Johnson & Johnson

Astria Therapeutics, Inc.

2 drugs

Related Conditions

gastrointestinalgiliverhepaticcirrhosiscrohnulcerative colitisibsgerdpancreatitisceliacconstipationdiarrhea